Tüdőrák: vizsgálatok itt: Franciaország
318 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleProspective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
- Where
- Nice
- Életkor
- 18 év and over
- People
- 200
- Run by
- Centre Antoine Lacassagne
See details and how to joinNCT06833229 - 1/2. fázisFut, nem toborozA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Dijon, Grenoble Cedex 9, Nice Cedex 2, Villejuif
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleEvolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
- Where
- Angers, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Lille, Lyon, Marseille, Montpellier, Mulhouse, Nantes, Nice, Paris, Reims, Rouen, Saint-Cloud, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 75 000
- Run by
- UNICANCER
See details and how to joinNCT03848052 - No phaseTaking peopleIMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy
- Where
- Marseille
- Életkor
- 18 év and over
- People
- 200
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT07608835 - No phaseTaking peopleA Clinico-biological Database of Lung Cancers
- Where
- Lille
- People
- 500
- Run by
- University Hospital, Lille
See details and how to joinNCT03387865 - 3. fázisNot yet taking people in FranciaországPhase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
- Where
- Lyon, Marseille, Paris, Rennes Cedex 9, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00 - 1. fázisTaking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Bron, Lyon Cedex 03, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - 3. fázisTaking peopleEfficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Where
- Bourdeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00 - No phaseTaking peopleEnvironment and Lung Cancer
- Where
- Le Plessis-Robinson, Paris, Villejuif
- Életkor
- 18 év to 59 év
- People
- 150
- Run by
- Centre Chirurgical Marie Lannelongue
See details and how to joinNCT05119244 - No phaseTaking peopleObservational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
- Where
- Aix-en-Provence, Bobigny, Bron, Caen, Créteil, Le Chesnay, Lille, Lyon, Marseille, Nancy, Nice, Paris, Pringy, Saint-Etienne, Saint-Pierre
- Életkor
- 18 év and over
- People
- 100
- Run by
- GFPC Investigation
See details and how to joinNCT07563205 - No phaseTaking peopleAnalysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
- Where
- Aix-en-Provence, Amiens, Angers, Annecy, Brest, Caen, Chambéry, Clermont-Ferrand, Créteil, Évreux, La Roche-sur-Yon, Le Chesnay, Le Mans, Lille, Limoges, Lorient, Lyon, Mantes-la-Jolie, Marseille, Meaux, Montpellier, Morlaix, Orléans, Paris, Pau, Pessac, Rennes, Rouen, Saint-Brieuc, Saint-Denis, Saint-Pierre, Saint-Priest-en-Jarez, Strasbourg, Suresnes, Talence, Toulon, Toulouse, Vannes, Villefranche-sur-Saône, Villejuif, Villeneuve-Saint-Georges
- Életkor
- 18 év and over
- People
- 100
- Run by
- Groupe Francais De Pneumo-Cancerologie
See details and how to joinNCT05122806 - No phaseTaking peopleMechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
- Where
- Bordeaux, Brest, Créteil, Dijon, Grenoble, Le Mans, Marseille, Nice, Paris, Pau, Quimper, Rouen, Saint-Denis, Saint-Etienne, Vannes, Villeurbanne
- Életkor
- 18 év and over
- People
- 30
- Run by
- Groupe Francais De Pneumo-Cancerologie
See details and how to joinNCT06247826 - 2. fázisTaking peopleTrial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
- Where
- Brest, Caen, Chambéry, Colmar, Créteil, Dijon, Épagny, La Chaussée-Saint-Victor, La Roche-sur-Yon, Limoges, Lyon, Marseille, Nancy, Nice, Nîmes, Orléans, Paris, Pessac, Rennes, Rouen, Saint-Etienne, Saint-Pierre, Strasbourg, Toulon, Vannes, Villefranche-sur-Saône
- Életkor
- 18 év and over
- People
- 45
- Run by
- Groupe Francais De Pneumo-Cancerologie
See details and how to joinNCT06620835 - 4. fázisTaking peoplePROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
- Where
- Aix-en-Provence, Avignon, Bastia, Brest, Caen, Chambéry, Cherbourg, Clermont-Ferrand, Colmar, Créteil, Elbeuf, La Chaussée-Saint-Victor, La Rochelle, La Roche-sur-Yon, Le Chesnay, Libourne, Limoges, Longjumeau, Lyon, Marseille, Meaux, Nancy, Orléans, Paris, Perpignan, Pringy, Quimper, Rennes, Rouen, Saint-Denis, Saint-Etienne, Saint-Nazaire, Saint-Pierre, Strasbourg, Toulon, Vannes, Villefranche-sur-Saône
- Életkor
- 70 év and over
- People
- 500
- Run by
- GFPC Investigation
See details and how to joinNCT06646471 - No phaseTaking peopleLong-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
- Where
- Aix-en-Provence, Angers, Avignon, Bastia, Bobigny, Brest, Bron, Caen, Cherbourg, Clermont-Ferrand, Colmar, Créteil, Elbeuf, Évreux, Jossigny, La Rochelle, La Roche-sur-Yon, Libourne, Longjumeau, Lorient, Lyon, Marseille, Meaux, Nancy, Nantes, Paris, Pau, Perpignan, Reims, Rennes, Rouen, Saint-Etienne, Saint-Jean-de-Verges, Saint-Pierre, St-Malo, Toulon, Toulouse, Vannes, Villefranche-sur-Saône
- Életkor
- 18 év and over
- People
- 1000
- Run by
- GFPC Investigation
See details and how to joinNCT07243132 - No phaseTaking peopleRATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
- Where
- Marseille, Rouen
- People
- 100 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07541521 - No phaseTaking peopleReal-Time Imaging to Improve Lung Cancer Diagnosis : Comparing Confocal Laser Endomicroscopy (CLE) With Standard Biopsy for Quicker and Safer Detection of Non-Small Cell Lung Cancer
- Where
- Nancy
- Életkor
- 18 év and over
- People
- 70
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT07538947 - No phaseTaking peopleDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
- Where
- Marseille, Rouen
- People
- 200 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07528066 - 1. fázisFut, nem toborozPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Dijon, Pierre-Bénite, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - 3. fázisTaking peopleFirst-line immunotherapy-based standard of care and local ablative treatments for oligometastatic non-small cell lung cancer patients: a randomized, multicentre, open-label phase III study (OliGRAIL)
- Where
- Avignon, Brest, Bron, Caen Cedex 5, Creil Cedex, Creteil Cedex, Dijon, Lille, Lyon Cedex 04, Nice, Nice Cedex 2, Nîmes, Paris, Pierre-Bénite, Rennes Cedex, Rouen, Saint-Cloud, Toulouse, Vandouvre Les Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 130
- Run by
- Institut Gustave Roussy
See details and how to join2023-503326-39-00 - No phaseTaking peopleClinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.
- Where
- Paris
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- Endowave Ltd.
See details and how to joinNCT07291973 - 1. fázisTaking peopleStudy to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
- Where
- Bordeaux, Lille, Lyon, Marseille, Nice, Rennes, Villejuif
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- DeuterOncology
See details and how to joinNCT05752552 - 2. fázisTaking peopleOral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
- Where
- Dijon, Grenoble, Paris, Suresnes, Toulon, Villejuif
- Életkor
- 18 év and over
- People
- 162
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07001618 - No phaseTaking peopleLung Cancer Screening With Low-dose CT Scan in Women : Implementation Study
- Where
- Paris
- Életkor
- 50 év to 74 év
- People
- 2635
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05195385 - No phaseTaking peopleCohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
- Where
- Villejuif
- Életkor
- 18 év and over
- People
- 5909
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06907095